Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma
Open Access
- 31 March 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (9), 5387-5401
- https://doi.org/10.1111/jcmm.15195
Abstract
Oesophageal squamous cell carcinoma (ESCC), the most common form of oesophageal malignancies in the Asia‐Pacific region, remains a major clinical challenge. In this study, we found that ivermectin, an effective antiparasitic drug that has been approved for patients to orally treat onchocerciasis for over 30 years, displayed potent antitumour activity against ESCC cells in vitro and in nude mice. We demonstrated that ivermectin significantly inhibited cell viability and colony formation, and induced apoptosis through a mitochondrial‐dependent manner in ESCC cells. Ivermectin also abrogated ESCC cell migration, invasion, as well as the protein levels of MMP‐2 and MMP‐9. Mechanistically, ivermectin strongly inhibited the expression of PAK1; by further gain‐ and loss‐of‐function experiments, we confirmed that PAK1 played a crucial role in ivermectin‐mediated inhibitory effects on ESCC cells. In addition, the data indicated that ivermectin promoted PAK1 degradation through the proteasome‐dependent pathway. Additionally, ivermectin synergized with chemotherapeutic drugs including cisplatin and 5‐fluorouracil to induce apoptosis of ESCC cells. Interestingly, the in vivo experiments also confirmed that ivermectin effectively suppressed tumour growth and lung metastasis of ESCC. Collectively, these results indicate that ivermectin exerts a potent antitumour activity against ESCC and is a promising therapeutic candidate drug for ESCC patients, even those carrying metastasis.Keywords
Funding Information
- National Natural Science Foundation of China (81573465, 81772832)
This publication has 43 references indexed in Scilit:
- DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathwayMolecular Cancer, 2013
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingOncogene, 2011
- The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cellsBlood, 2010
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathwayOncogene, 2008
- Characterization of Ser338 Phosphorylation for Raf-1 ActivationJournal of Biological Chemistry, 2008
- New uses for old drugsNature, 2007
- Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelminticsParasitology, 2005
- Ivermectin, an antiparasitic agentMedicinal Research Reviews, 1993
- Avermectin B1a, a paralyzing anthelmintic that affects interneurons and inhibitory motoneurons in Ascaris.Proceedings of the National Academy of Sciences, 1980